Norroy Bioscience Sustainability Profile
Norroy Bioscience, a leading name in the biotechnology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2015, the company has rapidly established itself as a key player in the development of innovative biopharmaceuticals and advanced diagnostic solutions. Specialising in cutting-edge gene editing and synthetic biology, Norroy Bioscience offers unique products that enhance research capabilities and therapeutic applications. Their commitment to quality and innovation has positioned them favourably in the competitive biotech landscape, earning recognition for their contributions to personalised medicine and disease management. With a focus on sustainability and scientific excellence, Norroy Bioscience continues to push the boundaries of biotechnology, striving to improve health outcomes globally. Their notable achievements reflect a dedication to advancing the industry while addressing critical healthcare challenges.
DitchCarbon Score
How does Norroy Bioscience's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Norroy Bioscience's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Norroy Bioscience's reported carbon emissions
Norroy Bioscience, headquartered in CN, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the organisation. This lack of data suggests that Norroy Bioscience may still be in the early stages of developing its climate commitments or may not have publicly disclosed its emissions profile. In the context of the industry, many organisations are increasingly adopting science-based targets and committing to significant reductions in greenhouse gas emissions. However, without specific initiatives or targets from Norroy Bioscience, it is unclear how they align with these industry standards. As the climate landscape evolves, it will be essential for Norroy Bioscience to establish and communicate its carbon reduction strategies to meet stakeholder expectations and contribute to global climate goals.
How Carbon Intensive is Norroy Bioscience's Industry?
How Carbon Intensive is Norroy Bioscience's Location?
Norroy Bioscience's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Norroy Bioscience has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
